dc.creatorCorrales Aguilar, Eugenia
dc.creatorHoffmann, Katja
dc.creatorHengel, Hartmut
dc.date.accessioned2019-02-27T20:56:25Z
dc.date.accessioned2019-04-25T15:37:17Z
dc.date.available2019-02-27T20:56:25Z
dc.date.available2019-04-25T15:37:17Z
dc.date.created2019-02-27T20:56:25Z
dc.date.issued2014-10-07
dc.identifierhttps://link.springer.com/article/10.1007/s00281-014-0448-2
dc.identifier1863-2300
dc.identifierhttp://hdl.handle.net/10669/76626
dc.identifier10.1007/s00281-014-0448-2
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/2385937
dc.description.abstractThe constant region of IgG antibodies mediates antiviral activities upon engaging host Fcγ receptors (FcγRs) expressed by a variety of immune cells, such as antibody-dependent cellullar cytotoxcity (ADCC) executed by natural killer (NK)cells. Human cytomegalovirus (HCMV) is unique among viruses by encoding also an array of several Fcγ-binding glycoproteins with cell surface disposition and concomitant incorporation into the virion. Evidence is increasing that the virus-encoded Fcγ receptors differ in their Fcγ binding mode but effectively operate as adversaries of host FcγRs since they are able to prevent IgG-mediated triggering of activating host FcγRs, i.e., FcγRI, FcγRIIA, and FcγRIIIA. Here we discuss virus-encoded FcγRs as the first known HCMV inhibitors of IgG-mediated immunity which could account for the limited efficacy of HCMV hyperimmune globulin in clinical settings. A better understanding of their molecular mode of action opens up new perspectives for improving IgG therapies against HCMV disease.
dc.languageen_US
dc.relation
dc.sourceSeminars in Immunopathology, vol. 36(6), pp. 627–640
dc.subjectFcγRs
dc.subjectImmune evasion
dc.subjectCytomegalovirus
dc.subjectIgG
dc.subjectADCC
dc.titleCMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución